Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19204219 | 0.97 | CA1 (0.31) | CA1CA2 | |
| SCHEMBL19523382 | 0.93 | — | — | |
| SCHEMBL19204179 | 0.93 | — | — | |
| SCHEMBL16264079 | 0.93 | MEN1 (0.35) | — | |
| SCHEMBL15500315 | 0.92 | — | — | |
| SCHEMBL10046525 | 0.88 | EPHX2 (0.38) | — | |
| SCHEMBL19523385 | 0.88 | — | — | |
| SCHEMBL12976858 | 0.85 | — | — | |
| SCHEMBL17690255 | 0.84 | MCL1 (0.30) | — | |
| SCHEMBL10046297 | 0.84 | EPHX2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919941-B2 | Functional lipid constructs | KODE BIOTECH LIMITED (NZ) | 2021-02-16 | — | — | US | disclosed |
| US-9802981-B2 | Functional lipid constructs | KODE BIOTECH LIMITED (NZ) | 2017-10-31 | — | — | US | disclosed |
| US-20170218027-A1 | FUNCTIONAL LIPID CONSTRUCTS | KODE BIOTECH LIMITED (NZ) | 2017-08-03 | — | — | US | disclosed |
| US-20140350217-A1 | FUNCTIONAL LIPID CONSTRUCTS | KODE BIOTECH LIMITED (NZ) | 2014-11-27 | — | — | US | disclosed |
| US-8669084-B2 | Functional lipid constructs | KODE BIOTECH LIMITED (NZ) | 2014-03-11 | — | — | US | disclosed |
| US-20120021430-A1 | FUNCTIONAL LIPID CONSTRUCTS | KODE BIOTECH LIMITED (NZ) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170218027-A1 | FUNCTIONAL LIPID CONSTRUCTS | CETP, LCAT, LIPA | CA1 1029/4885CA2 2207/4885TERT 2332/4885 |
| US-10919941-B2 | Functional lipid constructs | CETP, LCAT, LIPA | CA1 1029/4885CA2 2207/4885TERT 2332/4885 |
| US-20140350217-A1 | FUNCTIONAL LIPID CONSTRUCTS | CETP, LCAT, SGMS1 | CA1 557/4885CA2 1281/4885TERT 2472/4885 |
| US-20120021430-A1 | FUNCTIONAL LIPID CONSTRUCTS | CETP, LCAT, SGMS1 | CA1 557/4885CA2 1281/4885TERT 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.